NASDAQ: TARS
Tarsus Pharmaceuticals Inc Earnings Dates, Reports, Calls

Tarsus Pharmaceuticals earnings were -$48.3M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest TARS earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$7.0M, down 16.8% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, TARS reported annual earnings of -$66.4M, with -42.5% growth. The next TARS earnings date is Aug 5, 2026.

TARS earnings history

Current Revenue
$535.1M
Current Earnings
-$48.3M
Current Profit Margin
-9%

TARS Return on Equity

Current Company
-14.2%
Current Industry
-141.9%
Current Market
13.5%
TARS's Return on Equity (-14.2%)... subscribe to Premium to read more.
High Return on Equity Performance

TARS Return on Assets

Current Company
-8.9%
Current Industry
-13.7%
TARS is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when TARS announces earnings.

TARS Return on Capital Employed

Current Company
-8%
Current Industry
-9.6%
TARS has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TARS vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
TARS-$32.62M-$48.27MN/A-$1.13
IMNM-$221.61M-$224.59MN/A-$2.38
TRVI-$45.54M-$45.61MN/A-$0.32
KOD-$204.73M-$230.66MN/A-$4.17
BEAM-$42.67M-$65.04MN/A-$0.50

TARS earnings dates

Next earnings date
Aug 5, 2026

Tarsus Pharmaceuticals Earnings Reports & History FAQ

What were Tarsus Pharmaceuticals's earnings last quarter?

On TARS's earnings call on May 12, 2026, Tarsus Pharmaceuticals (NASDAQ: TARS) reported Q1 2026 earnings per share (EPS) of -$0.16, up 75% year over year. Total TARS earnings for the quarter were -$6.97 million. In the same quarter last year, Tarsus Pharmaceuticals's earnings per share (EPS) was -$0.64.

If you're new to stock investing, here's how to buy Tarsus Pharmaceuticals stock.

When does Tarsus Pharmaceuticals report earnings?

The next TARS earnings date is Aug 5, 2026. Add TARS to your watchlist to be reminded of Tarsus Pharmaceuticals's next earnings date.

Is Tarsus Pharmaceuticals profitable or losing money?

As of the last Tarsus Pharmaceuticals earnings report, Tarsus Pharmaceuticals is currently losing money. Tarsus Pharmaceuticals's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$48.27 million, a 54.01% decrease year over year.

What was TARS's earnings growth in the past year?

As of Tarsus Pharmaceuticals's earnings date in May 12, 2026, Tarsus Pharmaceuticals's earnings has grown year over year. TARS earnings in the past year totalled -$48.27 million.

What are Tarsus Pharmaceuticals's earnings expectations?

The current EPS estimate for Tarsus Pharmaceuticals's earnings report in Aug 5, 2026 is -$0.21.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.